Medical Radiology and Radiation Safety. 2026. Vol. 71. № 6

DOI:10.33266/1024-6177-2026-71-6-25-31

A.V. Smirnova, F.A. Malakhov, W. Xue, Y. Wang, J.M. Rozenberg, D.V. Kuzmin, M.V. Pustovalova, S.V. Leonov

THE EFFECT OF NON-CODING RNAS OF THE MIR-16 FAMILY ON THE SENSITIVIT OF AN OSTEOSARCOMA CELL LINE TO X-RAY IRRADIATION AND CISPLATIN TREATMENT

Institute of Future Biophysics, Dolgoprudny, Moscow Region, Russia

Contact person: M.V. Pustovalova, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

ABSTRACT

Purpose: The aim of this study was to examine how increased expression of microRNAs miR-16 and its passenger strands miR-16-1-3p and miR-16-2-3p influences key biological characteristics of the human osteosarcoma HOS cell line.

Material and methods:Stable HOS sublines overexpressing the guide strand (miR-16-5p) and the two passenger strands (miR-16-1-3p and miR-16-2-3p) were generated using lentiviral vectors, with an empty vector serving as the control. The sublines were analyzed using clonogenic assays to assess colony-forming ability before and after irradiation, Boyden chamber migration assays to evaluate changes in motility and radiosensitivity, SRB assays to determine cisplatin sensitivity, real-time proliferation analysis with the xCELLigence RTCA system, and metabolic activity assessment using the Alamar Blue assay.

Results: Elevated expression of both guide and passenger strands of miR-16 significantly reduced colony formation under baseline conditions and following X-ray irradiation, with the strongest effect observed for the passenger strands. All three microRNAs reduced cell migration through membrane pores and increased sensitivity to cisplatin, as reflected by decreased IC₅₀ values. Notably, overexpression of miR-16-1-3p led to marked proliferation slowdown and more than a two-fold increase in doubling time. Enhanced miR-16 expression also reduced metabolic activity both before and after irradiation.

Conclusion: Increased expression of miR-16 family microRNAs enhanced the sensitivity of osteosarcoma cells to radiation and cisplatin, while impairing their migratory and repopulation capacities. These findings indicate that miR-16 microRNAs may represent promising candidates for inclusion in combined targeted therapeutic approaches for osteosarcoma.

Keywords:  osteosarcoma, metastasis, microRNA, X-ray irradiation, cisplatin, proliferation,miR-16, miR-16-1-3p, miR-16-2-3p

For citation: Smirnova AV, Malakhov FA, Xue W, Wang Y, Rozenberg JM, Kuzmin DV, Pustovalova MV, Leonov SV. The Effect of Non-Coding RNAs of the miR-16 Family on the Sensitivity of an Osteosarcoma Cell Line to X-Ray Irradiation and Cisplatin Treatment. Medical Radiology and Radiation Safety. 2026;71(6):25–31. DOI:10.33266/1024-6177-2026-71-6-25-31

 

References

1. Jones K.B., Salah Z., Del Mare S., Galasso M., Gaudio E., Nuovo G.J., et al. MiRNA Signatures Associate with Pathogenesis and Progression of Osteosarcoma. Cancer Res 2012;72:1865–77. Doi: 10.1158/0008-5472.CAN-11-2663.

2. Zhao X., Wu Q., Gong X., Liu J., Ma Y. Osteosarcoma: a Review of Current and Future Therapeutic Approaches. Biomed Eng Online 2021;20:24. Doi: 10.1186/s12938-021-00860-0.

3. Hattinger C.M., Patrizio M.P., Fantoni L., Casotti C., Riganti C., Serra M. Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies. Cancers 2021;13:2878. Doi: 10.3390/cancers13122878.

4. Altuvia Y. Clustering and Conservation Patterns of Human MicroRNAs. Nucleic Acids Res 2005;33:2697–706. Doi: 10.1093/nar/gki567.

5. Lee Y., Kim M., Han J., Yeom K-H., Lee S., Baek S.H., et al. MicroRNA Genes are Transcribed by RNA Polymerase II. EMBO J. 2004;23:4051–60. Doi: 10.1038/sj.emboj.7600385.

6. Zeng Y., Cullen B.R. Sequence Requirements for Micro RNA Processing and Function in Human Cells. RNA 2003;9:112–23. Doi: 10.1261/rna.2780503.

7. Gregory R.I., Chendrimada T.P., Cooch N., Shiekhattar R. Human RISC Couples MicroRNA Biogenesis and Posttranscriptional Gene Silencing. Cell 2005;123:631–40. Doi: 10.1016/j.cell.2005.10.022.

8. Kawamata T., Tomari Y. Making RISC. Trends Biochem Sci 2010;35:368–76. Doi: 10.1016/j.tibs.2010.03.009.

9. Schwarz D.S., Hutvágner G., Du T., Xu Z., Aronin N., Zamore P.D. Asymmetry in the Assembly of the RNAi Enzyme Complex. Cell 2003;115:199–208. Doi: 10.1016/S0092-8674(03)00759-1.

10. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., et al. Frequent Deletions and Down-Regulation of MicroRNA Genes MiR15 and MiR16 at 13q14 in Chronic Lymphocytic Leukemia. Proc Natl Acad Sci 2002;99:15524–9. Doi: 10.1073/pnas.242606799.

11. Yang L., Yang S., Ren C., Liu S., Zhang X., Sui A. Deciphering the Roles of MiR-16-5p in Malignant Solid Tumors. Biomed Pharmacother 2022;148:112703. Doi: 10.1016/j.biopha.2022.112703.

12. Ye T., Liang Y., Zhang D., Zhang X. MicroRNA-16-1-3p Represses Breast Tumor Growth and Metastasis by Inhibiting PGK1-Mediated Warburg Effect. Front Cell Dev Biol 2020;8:615154. Doi: 10.3389/fcell.2020.615154.

13. Han T, Wu N, Wang Y, Shen W, Zou J. MiR‑16‑2‑3p Inhibits Cell Proliferation and Migration and Induces Apoptosis by Targeting PDPK1 in Maxillary Primordium Mesenchymal Cells. Int J Mol Med 2019. Doi: 10.3892/ijmm.2019.4070.

 

 PDF (RUS) Full-text article (in Russian)

 

Conflict of interest.The authors declare no conflict of interest.

Financing. The study was financially supported by a grant from the Russian Science Foundation (No. 23-14-00220) and the Ministry of Science and Higher Education of the Russian Federation, project FSMG-2026-0018 (agreement dated January 16, 2026 No. 075-03-2026-305).

Contribution.  Article was prepared with equal participation of the authors.

Article received: 20.06.2026. Accepted for publication: 25.07.2026.